Content area

|
|

Hurtig identifikation af patienter med neutropeni og feber bedrer prognosen

Forfatter(e)
Sofia Johansson1, 2 & Lars Henrik Jensen2 1) Kardiologisk, Nefrologisk og Endokrinologisk Afdeling, Nordsjællands Hospital 2) Onkologisk Afdeling, Vejle Sygehus Ugeskr Læger 2015;177:V03150240
Reference: 
Ugeskr Læger 2015;177:V03150240
Blad nummer: 
Sidetal: 
2-5
Fast identification of febrile neutropenia improves the outcome
The purpose of this article is to describe the management of febrile neutropenia in the medical emergency room. Symptoms and signs of inflammation in patients receiving chemotherapy may be blunted or absent and fever may be the only sign of severe infection. Early initiation of empirical antibiotics is essential for the outcome. A beta-lactam antibiotic is the treatment of choice and the regimen should be re-evaluated frequently in absence of clinical improvement. The treating oncologist should always be involved for advice and for assuring adjustments in future chemotherapy.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Camilla Bang | 29/11
2 kommentarer
af Stine Madsen-Østerbye | 29/11
1 Kommentar
af Kaj Seidelin | 29/11
6 kommentarer
af Pedram Kazemi-Esfarjani | 28/11
2 kommentarer
af Ulf Bern Jensen | 24/11
2 kommentarer
af Bodil Marie Nielsen | 24/11
2 kommentarer
af Toke Seierøe Barfod | 23/11
2 kommentarer
af Thorkild I.A. Sørensen | 20/11
1 Kommentar
af Kim Varming | 20/11
1 Kommentar